# Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Source: https://onco.cc/trials/nct05796375/  
OnCo record `nct05796375` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Bladder EpiCheck urine methylation test in Non-muscle-invasive bladder cancer, run by White River Junction Veterans Affairs Medical Center, now recruiting.

## Summary

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance is a phase 2 interventional study registered as NCT05796375 by White River Junction Veterans Affairs Medical Center, with 240 participants planned, started 2023-11-17 and due to reach its primary completion in 2028-11-30. Interventions recorded: Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test. Conditions recorded: Non-muscle-invasive Bladder Cancer.

Linked to the technology Bladder EpiCheck urine methylation test because the registry names it ("epicheck") among its interventions and Non-muscle-invasive bladder cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05796375
- Phase: 2
- Setting: Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- Sponsor: White River Junction Veterans Affairs Medical Center
- Enrolled: 240

## Sources

- ClinicalTrials.gov NCT05796375: https://clinicaltrials.gov/study/NCT05796375

## Connected records

- cancers: [Non-muscle-invasive bladder cancer](https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/)
- technologies: [Bladder EpiCheck urine methylation test](https://onco.cc/technologies/bladder-epicheck/)

---
JSON: https://onco.cc/api/v1/entities/nct05796375.json